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Abstract
Primary hepatic mucosa-associated lymphoid tissue (MALT) lymphoma is an extremely rare disease. We herein
describe the findings in a 74-year-old man with elevated liver enzyme levels. Dynamic computed tomography
showed focal biliary dilation and atrophy in the posterior segment, while dynamic magnetic resonance images
revealed a small, highly enhanced small mass located at the root of posterior branch of the biliary ducts. As the
mass was not detected on abdominal ultrasonography, a biopsy could not be performed. Cholangiocellular
carcinoma was suspected, and surgery was performed. However, the surgically resected hepatic tumor was a
nodule of aggregated lymphocytes that formed a lymphoepithelial lesion. Immunohistochemical analysis
revealed that the lymphoma cells were positive for CD20 and CD79a, but negative for CD3. No other lymphoid
lesions were found during additional postoperative examinations. Therefore, the patient was diagnosed with
primary hepatic MALT lymphoma. He was also diagnosed with Helicobacter pylori infection, and thus, pylorus
eradication was performed. At the time of this report, the patient was free of disease for 2 years without any
additional treatment. The present case contributed to the diagnosis and management of this rare disease, as
previously published case reports described varying imaging features; it also suggested that preoperative
diagnosis was often difficult without biopsy.
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Background
Mucosa-associated lymphoid tissue (MALT) lymphoma
is a low-grade malignant lymphoma that was first described
by Isaacson and Wright in 1983 [1]. The stomach is one of
the most common sites of MALT lymphoma development,
and gastric MALT lymphoma is commonly associated
with Helicobacter pylori (HP) infection. However, primary
hepatic lymphoma (PHL) is very rare, accounting for ap-
proximately only 0.016 % of all cases of all non-Hodgkin’s
lymphoma cases [2]. Furthermore, primary hepatic MALT
lymphoma is extremely rare among the diagnosed PHL
cases. In addition, the standard diagnostic method and
treatment strategy of this disease have yet to be estab-
lished. Herein, we describe a case of surgically resected
primary hepatic MALT lymphoma, which was initially
suspected to be a cholangiocellular carcinoma, and review
the relevant literature.
Case presentation
A 74-year-old man was referred to our department for
mild elevation of liver enzyme levels. He had no significant
medical history except for hypertension that was medically
managed. His family history was unremarkable. Physical
examination at presentation did not indicate any abnormal-
ities. The laboratory tests conducted at our hospital showed
the following findings: hemoglobin level of 17.4 g/dl, a
platelet count of 204,000/μl, albumin level of 4.5 g/dl,
total bilirubin level of 0.6 mg/dl, aspartate aminotrans-
ferase level of 22 IU/L, alanine aminotransferase level
of 34 IU/L, lactate dehydrogenase level of 160 IU/L,
γ-glutamyltranspeptidase level of 36 IU/L, alkaline phos-
phatase level of 338 IU/L, C-reactive protein level of
0.43 mg/dl, IgG level of 2199 mg/dl, and IgM level of
268.7 mg/dl. Hepatitis B surface antigen and anti-hepatitis
* Correspondence: punchnagata@live.jp
Department of Surgery, Iizuka Hosipital, Yoshiomachi 3-83, Iizuka, Fukuoka
820-8505, Japan
© 2015 Nagata et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Nagata et al. Surgical Case Reports  (2015) 1:87 
DOI 10.1186/s40792-015-0091-8
C virus antibody in the serum were negative. Anti-nuclear
antibody and anti-mitochondrial antibody were also nega-
tive. Tumor marker levels including carcinoembryonic
antigen, carbohydrate antigen 19-9, α-fetoprotein, and
des-γ-carboxy prothrombin were within the normal ranges.
Dynamic computed tomography (CT) with drip infusion
cholangiography revealed focal dilatation of the biliary
ducts and atrophy in the posterior segments of the liver
without any observable mass (Fig. 1a, b). The magnetic
resonance imaging (MRI) scans, T1- and T2-weighted im-
ages, did not show any mass. However, when gadolinium
was used as a contrast agent, a 1.5-cm mass located in the
area adjacent at the main posterior biliary duct was highly
enhanced on T1-weighted images during the arterial phase
but demonstrated rapid withdrawal in the portal venous
and delayed phases (Fig. 2). Gastroscopic and colonoscopic
examinations showed no ulcerative or tumorous lesion. As
the mass was not detected on abdominal ultrasonography
(US) and it could possibly be a malignant tumor such
as cholangiocellular carcinoma, the patient consented
to undergo a right hepatectomy with lymph node dissec-
tion in the hepatic portal region. Grossly, a 7-mm white
mass detected along with the posterior biliary duct was
soft and non-encapsulated like a lymph follicle (Fig. 3a).
Histologically, dense lymphocyte infiltration with some
lymphoid follicles was observed in the portal area (Fig. 3b).
Small- to middle-sized lymphocytes showed no apparent
atypia but formed lymphoepithelial lesions on some bile
capillaries (Fig. 3c, d). Immunohistochemical studies in-
dicated that the lymphocytes were positive for CD20 and
CD79a (Fig. 4), but negative for CD3. The patient was di-
agnosed with low-grade hepatic MALT lymphoma based
on the abovementioned pathological findings.
Subsequently, the patient’s level of interleukin-2 receptor
was found to be elevated at 1133 U/ml (normal range,
122–496 U/ml). He was also infected with HP and medical
Fig. 1 Computed tomography findings. a Dynamic computed tomography with drip infusion cholangiography revealed focal dilatation of the
biliary ducts (arrow) and atrophy (arrowheads) in the posterior segments of the liver. b No tumor was detected via enhanced computed tomography
Fig. 2 Enhanced magnetic resonance imaging after gadolinium
injection. The tumor was hyper-intense on T1-weighted images
(arrow) in the area adjacent to the main posterior biliary duct in the
arterial phase but showed rapid washout in the late phase
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treatment for pylorus eradication was provided. Biopsy
of the bone marrow revealed a normoplastic marrow.
Positron emission tomography demonstrated diffuse
accumulation in both the thyroid glands, with a maximum
standardized uptake value of 4.0. Biopsy of the thyroid
glands showed chronic thyroiditis without malignancy, and
the patient’s thyroid function was within normal limits. The
present case of MALT lymphoma was diagnosed a stage I
tumor, according to the Ann Arbor classification, and care-
ful follow-up without additional treatment was selected. At
the time of this report, the patient remained alive and free
of disease 2 years after surgery.
Discussion
MALT lymphoma often develops at several anatomic sites,
including the gastrointestinal tract, lungs, head and neck,
skin, thyroid glands, breasts, and liver. Gastric MALT
lymphoma is thought to be triggered by chronic inflam-
mation, which can occur in different diseases including
chronic gastritis associated with HP infection, Sjogren
syndrome, and Hashimoto thyroiditis [3]. The etiology
of primary hepatic MALT lymphoma is unclear, but it
has been reported that primary biliary cirrhosis [4–8],
hepatitis C viral infection [8–13], hepatitis B viral infection
[14–16], ascariasis [17, 18], and HP infection [19] are
possibly related with the pathogenesis of hepatic MALT
lymphoma.
At presentation, our patient was not infected with
hepatitis viruses, and his thyroid function and bone marrow
were normal. He was also negative for anti-nuclear and
anti-mitochondrial antibodies. However, his serum IgG and
IgM levels were elevated, and he showed HP infection.
Fig. 3 Tumor characteristics. a Grossly, the 7-mm white mass along the posterior biliary duct was soft and non-encapsulated. b Histological findings
on hematoxylin and eosin staining. The lesion consisted of dense lymphocyte infiltration with some lymph follicles. c and d Small to mid-sized
lymphocytes formed lymphoepithelial lesions on some bile capillaries
Fig. 4 Histological findings by immunohistochemical staining. Lymphocytes were diffusely positive for CD20 and CD79a antibodies
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Table 1 Reported cases of hepatic MALT lymphoma
Case Sex/age HBV HCV Concomitant disease Tumor no. Treatment Outcome
1 M/66 ND ND Ureteral cancer 1 Resection 12 M/alive
2 F/73 ND ND (−) 1 Resection Lost to follow-up
3 M/85 ND ND Prostatic cancer 2 (−) Death after other surgery
4 F/60 ND ND Liver cirrhosis Multiple Transplantation 12 M/dead
5 F/57 (−) ND Ascariasis 1 Resection 55 M/alive
6 M/48 (+) ND Hepatitis 1 Resection + Chemotherapy 38 M/alive
7 F/47 (−) (−) Multiple biliary unilocular cysts 1 Resection + Radiation 30 M/alive
8 M/64 (−) (−) Colon cancer 1 Resection Lost to follow-up
9 F/62 (−) (−) Primary biliary cirrhosis 1 Resection 6 M/alive
10 F/64 (−) (+) Liver cirrhosis 1 Chemotherapy 24 M/alive
11 F/65 (−) (+) Hepatitis 1 Chemotherapy 48 M/alive
12 F/69 (−) (−) (−) 1 Resection Short time/alive
13 F/41 (−) (−) Primary biliary cirrhosis 1 (−) 12 M/alive
14 F/64 (−) (−) (−) 1 Resection 72 M/alive
15 F/57 (−) (−) Primary biliary cirrhosis 1 Transplantation 9 M/alive
16 F/64 (−) (−) Ascariasis 1 Resection Pulmonary recurrence after 96 M
17 F/59 ND ND ND Multiple Resection + Chemotherapy ND
18 M/61 (−) (−) Gastric cancer 1 Resection 18 M/alive
19 M/73 (−) (+) Liver cirrhosis 1 Resection 34 M/alive
20 M/59 (−) (+) Hepatitis 1 Resection 30 M/alive
21 F/50 (−) (−) (−) 1 Resection + Chemotherapy 30 M/alive
22 F/72 ND ND Colon cancer 1 (−) 1 M/dead
23 F/61 ND ND Rheumatoid arthritis 1 (−) Dead
24 F/58 ND ND (−) Multiple Resection + Chemotherapy 37 M/alive
25 F/62 ND ND Breast cancer 1 Resection 9 M/alive
26 F/65 (+) (−) Hepatocellular carcinoma 1 Resection 10 M/alive
27 F/60 (−) (−) Gastric MALT lymphoma 1 (−) 30 M/alive
28 M/59 (+) (−) Liver cirrhosis 2 Transplantation 6 M/Alive
29 M/36 (+) (−) Hepatitis 1 Resection Hepatic recurrence after 40 M
30 M/53 (−) (+) Liver cirrhosis Multiple Transplantation + Chemo ND
31 M/67 (−) (−) Hepatitis (drug) 1 Radiation Pulmonary recurrence after 72 M
32 M/69 (−) (−) (−) 2 RFA + Chemo 24 M/alive
33 F/74 (−) (−) (−) 1 Resection + Chemotherapy 6 M/alive
34 F/67 NA NA Gastric MALT lymphoma Multiple (−) 1 M/dead
35 F/72 (−) (−) Colon cancer 1 Resection 24 M/alive
36 M/64 (−) (−) Gastric cancer Multiple (−) 24 M/alive
37 M/71 (−) (−) (−) 1 Resection 15 M/alive
38 M/71 (−) (−) (−) 1 Resection + Chemotherapy 45 M/alive
39 F/56 (−) (−) (−) 1 Resection Pulmonary recurrence after 84 M
40 M/59 (−) (−) (−) 1 Resection 5 M/alive
41 M/86 (+) (−) Hepatitis 1 (−) 15 M/alive
42 M/58 (−) (+) Hepatitis 1 Resection + Chemotherapy 6 M/alive
43 F/43 (−) (−) Gastric cancer 1 Resection 24 M/alive
44 F/80 (−) (−) Primary biliary cirrhosis Multiple Chemotherapy ND
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Such clinical findings suggested that the hepatic MALT
lymphoma might be strongly associated with chronic in-
flammation caused by HP infection. Subsequent treatment
for HP infection after surgery was successful.
For literature review, we searched PubMed and Ichushi
Web by Japan Medical Abstracts Society independently.
Key terms used included “MALT lymphoma,” “liver,”
“hepatic MALT lymphoma,” and “primary hepatic lymph-
oma. To our knowledge, there are 37 reports including 51
patients with primary hepatic MALT lymphoma [4–41]
(Table 1). The mean age of these 22 men and 29 women
was 64.0 years. In most cases, the hepatic tumors were
incidentally detected during surgical resection or on
follow-up imaging examination for liver diseases or other
conditions. In 24 patients (47 %), liver diseases concomi-
tantly existed (ascariasis, 2; primary biliary cirrhosis, 5;
hepatitis B, 4; hepatitis C, 6; drug induced hepatitis, 1;
cirrhosis without hepatitis viral infection, 5; and mul-
tiple biliary cysts, 1). Thus, hepatic MALT lymphoma
development might be related to chronic liver inflamma-
tion, similar to gastric MALT lymphoma. Thirty-eight
patients (74 %) had solitary mass, and the tumor size
was ≤3 cm in 22 of the 41 reported cases (53 %). Regarding
radiological characteristics, in 15 cases, the tumors were de-
scribed as detectable hypo-echoic masses via abdominal
US. In 21 cases, they were detected as low-density masses
via CT, including 6 cases with enhancement and 9 without.
In 16 cases with detailed MRI description, all tumors
showed high density on T1-weighted images and low
density on T2-weighted images. Two cases that described
contrast-enhanced MRI showed sickly enhancement in
the early phase. Both cases had solitary mass, and their
tumor sizes were 3 and 6.5 cm, respectively [27, 41]. Our
case showed highly enhanced mass in the early phase, but
not detected in abdominal US and CT. It is suggested that
these findings would be specific to small hepatic MALT
lymphoma. With regard to treatment, 31 patients (60.8 %)
underwent surgical resection with or without chemother-
apy or radiation therapy. Of these, 28 patients had a single
tumor, including 4 whose tumors were accidentally discov-
ered in the isolated liver from transplantation patients. In
addition, one patient underwent radiofrequency ablation,
five received chemotherapy only, and two received radiation
only. Eight patients did not receive any treatment, five of
whom died during the follow-up period. Recurrence was
reported in two patients.
According to the abovementioned case reports, primary
hepatic MALT lymphoma tends to be solitary and small.
Furthermore, it is often difficult to make a definite diagno-
sis of primary hepatic MALT lymphoma solely based
on the imaging findings as the disease seem to exhibit
variable imaging features. Therefore, it is necessary to
accumulate more cases and establish a therapeutic strategy
for primary hepatic MALT lymphoma.
Conclusions
In the present report, we described a case of primary
hepatic MALT lymphoma. Our experience in this case and
review of relevant literature indicated that preoperative
diagnosis of hepatic MALT lymphoma might be chal-
lenging because of the disease’s varying imaging fea-
tures. Thus, further study of this extremely rare disease
is necessary.
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